# Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

> **NCT01659853** · PHASE3 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 70 (actual)

## Conditions studied

- Erythema
- Rosacea

## Interventions

- **DRUG:** CD07805/47 gel 0.5%/CD07805/47 Vehicle
- **DRUG:** azelaic acid gel 15%

## Key facts

- **NCT ID:** NCT01659853
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01659853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01659853, "Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01659853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*